Estimating the seroprevalence of SARS-CoV-2 antibodies: Understanding population-level immunity in Albania at the end of the Alpha variant wave

J Glob Health. 2022 Jul 25:12:03054. doi: 10.7189/jogh.12.03054.

Authors

Fabian Cenko¹, Alban Ylli², Margarita Prifti³, Erkena Shyti³, Erina Lazri⁴, Melissa J Perry⁵, Genc Sulcebe^{3

6}

Affiliations

¹ Catholic University Our Lady of Good Counsel, Tirana, Albania.
² Institute of Public Health, Tirana, Albania.
³ Research Unit of Immunology, Academy of Sciences of Albania, Tirana, Albania.
⁴ University of Medicine, Faculty of Medical Technical Sciences, Tirana, Albania.
⁵ Milken Institute School of Public Health, The George Washington University, Washington DC, USA.
⁶ University of Medicine, Tirana, Albania.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Albania / epidemiology
Antibodies, Viral
COVID-19*
Humans
SARS-CoV-2*
Seroepidemiologic Studies

Substances

Antibodies, Viral

Supplementary concepts

SARS-CoV-2 variants